Lehrstuhl für Geburtshilfe und Frauenheilkunde

Feasibility and Acceptance of Self-Guided Mobile Ultrasound among Pregnant Women in Routine Prenatal Care (2023) Pontones C, Titzmann A, Hübner H, Danzberger N, Rübner M, Häberle L, Eskofier B, et al. Journal article Fertilität und Fertilitätserhalt der Frau (2023) Dittrich R, Lotz L Journal article, Review article Management of Cervical Intraepithelial Neoplasia in Pregnant Women (2023) Stübs F, Koch MC, Dietl A, Schulmeyer C, Behrens A, Seibold A, Adler W, et al. Journal article External-Beam-Accelerated Partial-Breast Irradiation Reduces Organ-at-Risk Doses Compared to Whole-Breast Irradiation after Breast-Conserving Surgery (2023) Ott O, Stillkrieg W, Lambrecht U, Schweizer C, Lamrani A, Sauer TO, Strnad V, et al. Journal article Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: An international multicentre analysis (2023) May T, Bernardini M, Lheureux S, Aben KK, Bandera EV, Beckmann M, Benitez J, et al. Journal article 2D:4D biomarker reliability and validity in a within-subject pregnancy-childhood-adolescence cohort (2023) Eichler A, Kaufmann F, Titzmann A, Fasching P, Beckmann M, Gerlach J, Kratz O, et al. Journal article The Benefit of a Retrospective Pregnancy Anamnesis in Child and Adolescent Psychiatry: The Reliability of Maternal Self-Report during Childhood Development (2023) Mestermann S, Fasching P, Beckmann M, Gerlach J, Kratz O, Moll G, Kornhuber J, Eichler A Journal article Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041) (2023) Fasching P, Hein A, Kolberg HC, Häberle L, Uhrig S, Rübner M, Belleville E, et al. Journal article Treatment of Early Breast Cancer: The 18th St. Gallen International Breast Cancer Consensus Conference against the Background of Current German Treatment Recommendations (2023) Untch M, Banys-Paluchowski M, Brucker SY, Budach W, Denkert C, Ditsch N, Fasching P, et al. Journal article Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer (2023) Denkert C, Lambertini C, Fasching P, Pogue-Geile KL, Mano MS, Untch M, Wolmark N, et al. Journal article